Compounds > atovaquone
Page last updated: 2024-08-25

atovaquone and Breast Neoplasms

atovaquone has been researched along with Breast Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF1
Du, Q; Li, Q; Luan, Y; Qin, X; Ren, X; Wang, N; Zhang, M; Zhao, Z1
Chen, A; Chen, X; Cheng, H; Guan, R; Li, S; Wang, C; Yang, N; Yu, X; Zhao, L; Zheng, R1
Gupta, N; Srivastava, SK1
Alves Dos Santos, R; de Oliveira Silva, E; Dos Santos Gonçalves, N; Jacometti Cardoso Furtado, NA1
Gruber, DM; Huber, JC; Sator, MO1

Reviews

1 review(s) available for atovaquone and Breast Neoplasms

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells

2022

Other Studies

5 other study(ies) available for atovaquone and Breast Neoplasms

ArticleYear
A mitochondrial-metabolism-regulatable carrier-free nanodrug to amplify the sensitivity of photothermal therapy.
    Chemical communications (Cambridge, England), 2021, Sep-06, Volume: 57, Issue:71

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Atovaquone; Breast Neoplasms; Cell Line, Tumor; Female; Indocyanine Green; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Oxidative Phosphorylation; Photosensitizing Agents; Photothermal Therapy

2021
A porphysome-based photodynamic O
    Chemical communications (Cambridge, England), 2021, Apr-27, Volume: 57, Issue:34

    Topics: Animals; Antineoplastic Agents; Atovaquone; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Female; Mice; Mitochondria; Molecular Structure; Oxygen; Photochemotherapy; Porphyrins

2021
Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.
    Molecular cancer therapeutics, 2019, Volume: 18, Issue:10

    Topics: Animals; Antiprotozoal Agents; Apoptosis; Atovaquone; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Silencing; Humans; Mice, Inbred BALB C; Paclitaxel; Proteasome Endopeptidase Complex; Receptor, ErbB-2; Signal Transduction

2019
Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.
    European journal of drug metabolism and pharmacokinetics, 2016, Volume: 41, Issue:5

    Topics: Animals; Antimalarials; Atovaquone; Breast Neoplasms; Caenorhabditis elegans; Cell Line; Cell Line, Tumor; Female; Fibroblasts; Fungi; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Metabolic Detoxication, Phase I; Proguanil

2016
Hormone replacement therapy and breast cancer.
    Lancet (London, England), 1997, Nov-29, Volume: 350, Issue:9091

    Topics: Atovaquone; Bias; Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Female; Humans; Naphthoquinones; Proguanil

1997